Commentary

The Sexual Revolution Has Been Great — For Men


 

What Can Be Done?

The regrettable situation does not reflect evil intent on the part of regulators, educators, or physicians. But the gap between what women want and what medical education and the pharmaceutical-regulatory complex are providing is intolerably wide.

First, I would recommend a standard, required curriculum for the study of female sexual anatomy and function be established and widely adopted by medical schools. The reproductive system contains different components and a different purpose from the orgasm system, with modest overlap. Both systems should be taught in every medical school.

Second, physicians should be required to undergo a course in understanding their own sexuality. Research demonstrates doctors will avoid conversations about sex, and it seems to me this could be secondary to being uncomfortable with their own sexuality. After all, to talk with a patient about sex, you cannot be fearful of where the conversation may lead.

Third, the FDA might reconsider the requirements for the approval of drugs for FSD. Currently, to approve a drug for men, an objective finding — ie, an erection — can be sufficient. However, a higher bar, “satisfaction,” which is subjective, must be obtained with women.

Regenerative therapies have proved helpful but are not yet widely adopted; more grant money for the study of regenerative therapies would be a good start here.

Finally, by the definition of FSD, a woman must be psychologically distressed. The idea of sex is not pleasure alone. Sexual function affects family relationships, emotional health, confidence, even sleep, as well as the emotional well-being of the children who live in the house. Saying women are wonderfully and mysteriously made may be poetic, but it is not an excuse for not learning more and closing the gaps.

Dr. Runels is medical director of the Cellular Medicine Association, Fairhope, Alabama. He reported conflicts of interest with the Cellular Medicine Association, Runels Research Institute, Institute for Lichen Sclerosus, and Vulvar Health. A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Pill not enough for ‘sexual problems’ female cancer patients face
MDedge Internal Medicine
Below the belt: sexual dysfunction overlooked in women with diabetes
MDedge Internal Medicine
Sacral nerve stimulation may aid female sexual dysfunction
MDedge Internal Medicine
Ninety-four women allege a Utah doctor sexually assaulted them. Here’s why a judge threw out their case
MDedge Internal Medicine
Unveiling sexual dysfunction: Clinicians can do more
MDedge Internal Medicine
A nurse’s view: Women desperately need information about pelvic floor disorders
MDedge Internal Medicine
Women’s Cancers: Clinicians Research, Advise on Sexual Dysfunction
MDedge Internal Medicine
Research Highlights From ESMO Breast Cancer
MDedge Internal Medicine
When Childhood Cancer Survivors Face Sexual Challenges
MDedge Internal Medicine
High Breast Cancer Risk With Menopausal Hormone Therapy & Strong Family History
MDedge Internal Medicine